A detailed history of Kearns & Associates LLC transactions in Danaher Corp stock. As of the latest transaction made, Kearns & Associates LLC holds 910 shares of DHR stock, worth $209,755. This represents 0.17% of its overall portfolio holdings.

Number of Shares
910
Previous 910 -0.0%
Holding current value
$209,755
Previous $227,000 11.01%
% of portfolio
0.17%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

BUY
$185.1 - $233.13 $168,441 - $212,148
910 New
910 $210,000
Q4 2022

Jan 20, 2023

BUY
$241.42 - $282.29 $219,692 - $256,883
910 New
910 $0

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Kearns & Associates LLC Portfolio

Follow Kearns & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kearns & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kearns & Associates LLC with notifications on news.